for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cigna Corp

CI.N

Latest Trade

161.50USD

Change

-4.00(-2.42%)

Volume

416,843

Today's Range

160.83

 - 

165.34

52 Week Range

141.98

 - 

226.58

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
165.50
Open
164.09
Volume
416,843
3M AVG Volume
43.20
Today's High
165.34
Today's Low
160.83
52 Week High
226.58
52 Week Low
141.98
Shares Out (MIL)
377.61
Market Cap (MIL)
62,494.34
Forward P/E
9.85
Dividend (Yield %)
0.02

Latest Developments

More

Cigna Corp Says Co's Officials Expect To Participate In Meetings With Investors And Analysts Over Next Several Weeks - SEC Filing

Cigna CFO Says "Normal Seasonality" Hurt Medical Care Ratio

Cigna Q2 Shareholders' Net Income Was $1.41 Bln, Or $3.70 Per Share

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cigna Corp

Cigna Corporation is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate. Its Global Health Care segment aggregates the commercial and Government operating segments. Its commercial operating segment encompasses the United States commercial and certain international healthcare businesses serving employers and their employees, other groups, and individuals. Its Global Supplemental Benefits segment offers supplemental health, life and accident insurance products in selected international markets and in the United States. Its Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, accident and specialty insurance and related services.

Industry

Insurance (Accident & Health)

Contact Info

900 Cottage Grove Rd

+1.860.2266000

https://www.cigna.com/

Executive Leadership

Isaiah Harris

Independent Chairman of the Board

David M. Cordani

President, Chief Executive Officer, Director

Eric P. Palmer

Chief Financial Officer, Executive Vice President

Brian C. Evanko

President - Government Business

Matthew G. Manders

President - Strategy and Solutions

Key Stats

1.88 mean rating - 25 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

39.5K

2017

41.4K

2018

48.1K

2019(E)

137.0K
EPS (USD)

2016

8.100

2017

10.460

2018

14.220

2019(E)

16.805
Price To Earnings (TTM)
15.14
Price To Sales (TTM)
0.61
Price To Book (MRQ)
1.45
Price To Cash Flow (TTM)
10.54
Total Debt To Equity (MRQ)
89.46
LT Debt To Equity (MRQ)
84.18
Return on Investment (TTM)
--
Return on Equity (TTM)
3.40

Latest News

Cigna closes $54 billion purchase of Express Scripts

Cigna Corp <CI.N> on Thursday closed its $54-billion deal to buy Express Scripts Holding Co, creating one of the biggest providers of pharmacy benefits and insurance plans in the United States, a combination it says will help it improve healthcare coordination and cut costs.

Cigna closes its $54 billion purchase of Express Scripts

Cigna Corp on Thursday closed its $54 billion deal to buy Express Scripts Holding Co, creating one of the biggest providers of pharmacy benefits and insurance plans in the United States, a combination it says will help it improve healthcare coordination and cut costs.

Cigna boosts 2018 forecast after third quarter earnings beat

U.S. health insurer Cigna Corp <CI.N>, which is in the process of acquiring Express Scripts Holding Co <ESRX.O>, significantly bumped up its 2018 adjusted profit forecast, and its shares rose more than 3 percent on Thursday.

Cigna's third-quarter profit rises driven by lower medical costs

Cigna Corp on Thursday reported a higher third quarter profit, helped by lower medical costs in its government healthcare plans.

Cigna-Express scripts deal gets anti-trust approval

Sept 17 - Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing a combination the companies say will lead to lower costs by better coordinating...

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

Cigna, Express Scripts shareholders approve $52 billion deal

Cigna Corp <CI.N> shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co <ESRX.O>, although the deal still needs clearance from antitrust authorities.

Cigna shareholders approve $52 bln Express Scripts acquisition

Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co, but the deal still needs antitrust approval to move forward.

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

Cigna-Express Scripts deal gets backing from another proxy firm

Cigna Corp said Glass Lewis & Co on Monday recommended its shareholders vote in favour for the proposed $52 billion acquisition of pharmacy benefits manager Express Scripts, the second proxy advisory firm to support the deal.

Advisory firm ISS backs Cigna's Express Scripts buy

Shareholder advisory firm Institutional Shareholder Services Inc (ISS) on Friday recommended that Cigna Corp <CI.N> investors vote for the health insurer's $52 billion purchase of pharmacy benefits manager Express Scripts <ESRX.O>, a deal that has been opposed by activist...

Glenview backs Cigna-Express Scripts deal after Icahn criticism

Hedge fund Glenview Capital Management on Thursday backed health insurer Cigna Corp's <CI.N> deal to buy pharmacy benefit manager Express Scripts <ESRX.O> in the face of stiff opposition from activist investor Carl Icahn ahead of a shareholder vote.

Icahn ratchets up pressure against Cigna-Express Scripts deal

Activist investor Carl Icahn fired the latest salvo against Cigna Corp's deal to buy pharmacy benefit manager Express Scripts, saying drug rebates that PBMs receive from drugmakers will ultimately be eliminated, dealing a blow to the industry.

Cigna beats lawsuit by Houston hospital over reduced payments

A federal judge has ruled against a Houston hospital operator who accused insurer Cigna Corp of wrongly reducing the amounts it reimbursed the hospital after determining it was waiving the out-of-network coinsurance payments it was supposed to collect from patients. U.S...

Icahn urges Cigna shareholders to vote against Express Scripts deal

Activist investor Carl Icahn on Tuesday urged Cigna Corp <CI.N> shareholders to vote against the health insurer's $52 billion purchase of Express Scripts Holding Co <ESRX.O>, citing regulatory hurdles and the growing threat from Amazon.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:

Icahn urges Cigna shareholders to vote against Express Scripts deal

Billionaire investor Carl Icahn on Tuesday urged Cigna Corp shareholders to vote against the health insurer's $52 billion acquisition of Express Scripts Holding Co .

Icahn to send letter to oppose Cigna-Express Scripts deal: WSJ

Investor Carl Icahn will send an open letter to the shareholders of insurer Cigna Corp <CI.N> asking them to vote against the company's $52 billion Express Scripts Holding Co <ESRX.O> buyout, the Wall Street Journal reported on Monday, citing a draft of the letter.

Cigna confident on Express Scripts deal as Icahn tussle looms

Cigna Corp <CI.N> said on Thursday it was confident of winning shareholder approval for its $52 billion Express Scripts buyout, a day after reports that investor Carl Icahn had picked up a stake in the insurer and was planning to vote against the deal.

Health insurer Cigna quarterly revenue rises about 11 pct

Health insurer Cigna Corp reported an about 11 percent rise in quarterly revenue on Thursday, helped by higher enrollment and premium increases.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up